209 related articles for article (PubMed ID: 6114837)
1. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
Wall ME; Brine DR; Perez-Reyes M
Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
[TBL] [Abstract][Full Text] [Related]
2. The metabolism of naltrexone in man.
Wall ME; Brine DR; Perez-Reyes M
NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone disposition in man after subcutaneous administration.
Wall ME; Perez-Reyes M; Brine DR; Cook CE
Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
[TBL] [Abstract][Full Text] [Related]
4. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
Reuning RH; Ashcraft SB; Wiley JN; Morrison BE
Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491
[TBL] [Abstract][Full Text] [Related]
5. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat.
Dayton HE; Inturrisi CE
Drug Metab Dispos; 1976; 4(5):474-8. PubMed ID: 10147
[TBL] [Abstract][Full Text] [Related]
6. Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs.
Ludden TM; Bathala MS; Malspeis L; Drum MA; Reuning RH
Drug Metab Dispos; 1978; 6(3):321-8. PubMed ID: 26554
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
[TBL] [Abstract][Full Text] [Related]
8. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
Taylor SM; Rodgers RM; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
[TBL] [Abstract][Full Text] [Related]
10. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
Verebey K
NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography.
Verebey K
NIDA Res Monogr; 1981; 28():36-51. PubMed ID: 6791012
[TBL] [Abstract][Full Text] [Related]
12. The identification and measurement of two new metabolites of naltrexone in human urine.
Cone EJ; Gorodetzky CW; Darwin WD; Carroll FI; Brine GA; Welch CD
Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):413-33. PubMed ID: 674824
[TBL] [Abstract][Full Text] [Related]
13. Overview of human pharmacokinetics of naltrexone.
Licko V
NIDA Res Monogr; 1981; 28():161-71. PubMed ID: 6791002
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.
Verebey K; Volavka J; Mulé SJ; Resnick RB
Clin Pharmacol Ther; 1976 Sep; 20(3):315-28. PubMed ID: 954353
[TBL] [Abstract][Full Text] [Related]
15. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the oral, intravenous, and subcutaneous administration of 3H-naltrexone to normal male volunteers.
Perez-Reyes M; Wall ME
NIDA Res Monogr; 1981; 28():93-101. PubMed ID: 6791016
[TBL] [Abstract][Full Text] [Related]
17. Analytical methods for quantitative and qualitative analysis of naltrexone and metabolites in biological fluids.
Wall ME; Brine DR
NIDA Res Monogr; 1981; 28():52-65. PubMed ID: 6791013
[TBL] [Abstract][Full Text] [Related]
18. Carbon-13 nuclear magnetic resonance identification of 2-hydroxy-3-O-methyl-6beta-naltrexol as a minor naltrexone metabolite.
Brine GA; Brine DR; Welch CD; Bondeson VC; Carroll FI
Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):455-64. PubMed ID: 734225
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.
Verebey K; Mulé SJ
NIDA Res Monogr; 1979; 27():296-301. PubMed ID: 121346
[No Abstract] [Full Text] [Related]
20. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
Bondesson U; Hartvig P; Danielsson B
Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
